{"entities":{"Q40687":{"pageid":31055,"ns":120,"title":"Item:Q40687","lastrevid":131851,"modified":"2026-08-13T06:35:54Z","type":"item","id":"Q40687","labels":{"mul":{"language":"mul","value":"6B00"},"pt-br":{"language":"pt-br","value":"Transtorno de ansiedade generalizada"},"en":{"language":"en","value":"Generalised anxiety disorder"}},"descriptions":{"pt-br":{"language":"pt-br","value":"Transtorno de ansiedade generalizada \u00e9 caracterizado por sintomas proeminentes de ansiedade que persistem por pelo menos v\u00e1rios meses, na maioria dos dias, manifestados ou por apreens\u00e3o geral (i.e., \"ansiedade livremente flutuante\") ou por preocupa\u00e7\u00e3o excessiva focada em m\u00faltiplos eventos cotidianos, mais frequentemente relacionados a fam\u00edlia, sa\u00fade, finan\u00e7as e escola ou trabalho, junto com sintomas adicionais como tens\u00e3o muscular ou inquieta\u00e7\u00e3o motora, hiperatividade auton\u00f4mica simp\u00e1tica, experi\u00eancia subjetiva de nervosismo, dificuldade de manter a concentra\u00e7\u00e3o, irritabilidade ou perturba\u00e7\u00e3o do sono. Os sintomas resultam em sofrimento significativo ou preju\u00edzo significativo na funcionalidade pessoal, familiar, social, educacional, ocupacional ou em outras \u00e1reas importantes da funcionalidade. Os sintomas n\u00e3o s\u00e3o manifesta\u00e7\u00e3o de outra condi\u00e7\u00e3o de sa\u00fade e n\u00e3o se devem a efeitos de uma subst\u00e2ncia ou medicamento sobre o sistema nervoso central."},"en":{"language":"en","value":"Generalised anxiety disorder is characterised by marked symptoms of anxiety that persist for at least several months, for more days than not, manifested by either general apprehension (i.e. \u2018free-floating anxiety\u2019) or excessive worry focused on multiple everyday events, most often concerning family, health, finances, and school or work, together with additional symptoms such as muscular tension or motor restlessness, sympathetic autonomic over-activity, subjective experience of nervousness, difficulty maintaining concentration, irritability, or sleep disturbance. The symptoms result in significant distress or significant impairment in personal, family, social, educational, occupational, or other important areas of functioning. The symptoms are not a manifestation of another health condition and are not due to the effects of a substance or medication on the central nervous system."}},"aliases":{},"claims":{"P68":[{"mainsnak":{"snaktype":"value","property":"P68","hash":"60ef28837bd710c8e2aa04acb0ffab9a8a0cdb33","datavalue":{"value":"https://id.who.int/icd/entity/1712535455","type":"string"},"datatype":"url"},"type":"statement","id":"Q40687$FBC374BD-08A4-42E9-9DF7-D0D2C9C50768","rank":"normal"}],"P67":[{"mainsnak":{"snaktype":"value","property":"P67","hash":"97078be6d6d57f7a5db06ae6d492bfc6dcc1eb7e","datavalue":{"value":"CID11:6B00","type":"string"},"datatype":"string"},"type":"statement","id":"Q40687$0CE48FEC-F86E-49B1-9FB9-D6CB8C5FF8CC","rank":"normal"}],"P70":[{"mainsnak":{"snaktype":"value","property":"P70","hash":"9876de83da8e36643d919b5ce646f84ce8518ad1","datavalue":{"value":"dki-india-6B00","type":"string"},"datatype":"string"},"type":"statement","id":"Q40687$A6DFF54D-6499-4216-AD49-62E8431C599A","rank":"normal"}],"P86":[{"mainsnak":{"snaktype":"value","property":"P86","hash":"a96031634b9f5dafddaf781bbba3adea6bb64ef4","datavalue":{"value":"Conclu\u00eddo","type":"string"},"datatype":"string"},"type":"statement","id":"Q40687$CD247294-280E-4F2C-8274-6A227D0E9598","rank":"normal"}],"P78":[{"mainsnak":{"snaktype":"value","property":"P78","hash":"5f9b5be68b7400da549761cf15abfdbc4d1e075b","datavalue":{"value":"https://pauloleads.com.br/cases-publicos/","type":"string"},"datatype":"url"},"type":"statement","id":"Q40687$B8242A14-3417-4D98-A2E8-B95BC0C1C01C","rank":"normal"}],"P80":[{"mainsnak":{"snaktype":"value","property":"P80","hash":"92b8222fcbb75718504f915073a3f43bd4003d18","datavalue":{"value":{"time":"+2026-08-13T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q40687$B467569D-F20A-4FB0-AD05-3FD2F0E2BDB0","rank":"normal"}],"P89":[{"mainsnak":{"snaktype":"value","property":"P89","hash":"fcbfc9b411ea18360d56e5dde4e686f2d8c2d38c","datavalue":{"value":{"entity-type":"item","numeric-id":16272,"id":"Q16272"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q40687$83D4F4F0-2AB9-4080-A96E-809049B4AB57","rank":"normal"}]},"sitelinks":{}}}}